Miragen Therapeutics Inc (MGEN):企業の財務・戦略的SWOT分析

【英語タイトル】Miragen Therapeutics Inc (MGEN) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(DATA904C5264)・商品コード:DATA904C5264
・発行会社(調査会社):GlobalData
・発行日:2018年9月
・ページ数:48
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Miragen Therapeutics Inc (MGEN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Miragen Therapeutics, Inc. (Miragen) is a clinical stage biopharmaceutical company. It discovers and develops RNA-targeted therapeutics with a focus on microRNAs and their role in diseases. The company is developing its pipeline products for the treatment of Cutaneous T-Cell Lymphoma (CTCL), Adult T-Cell Lymphoma/Leukemia, Diffuse Large-B Cell Lymphoma, Chronic Lymphocytic Leukemia, ALS, Heart Failure, Incisional Complications, Cutaneous Fibrosis, Idiopathic Pulminary Fibrosis and Other Fibrotic Indications. The pipeline development is focused on microRNA platform that regulate gene expression and influences the pathways responsible for many disease processes. Miragen is headquartered in Boulder, Colorado, the US.

Miragen Therapeutics Inc Key Recent Developments

Aug 07,2018: miRagen Therapeutics announces second quarter 2018 financial results
May 09,2018: miRagen Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
Mar 14,2018: miRagen Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
Jan 05,2018: miRagen Therapeutics Expands Board of Directors With Appointment of Arlene Morris
Nov 08,2017: miRagen Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Miragen Therapeutics Inc – Key Facts 6
Miragen Therapeutics Inc – Key Employees 7
Miragen Therapeutics Inc – Key Employee Biographies 8
Miragen Therapeutics Inc – Major Products and Services 9
Miragen Therapeutics Inc – History 10
Miragen Therapeutics Inc – Company Statement 11
Miragen Therapeutics Inc – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Company Overview 13
Miragen Therapeutics Inc – Business Description 14
R&D Overview 14
Miragen Therapeutics Inc – Corporate Strategy 15
Miragen Therapeutics Inc – SWOT Analysis 16
SWOT Analysis – Overview 16
Miragen Therapeutics Inc – Strengths 16
Miragen Therapeutics Inc – Weaknesses 17
Miragen Therapeutics Inc – Opportunities 18
Miragen Therapeutics Inc – Threats 19
Miragen Therapeutics Inc – Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios – Capital Market Ratios 21
Financial Ratios – Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios – Interim Ratios 25
Financial Ratios – Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
Miragen Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 27
Miragen Therapeutics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 28
Miragen Therapeutics Inc, Recent Deals Summary 29
Section 5 – Company’s Recent Developments 30
Aug 07, 2018: miRagen Therapeutics announces second quarter 2018 financial results 30
May 09, 2018: miRagen Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update 32
Mar 14, 2018: miRagen Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update 34
Jan 05, 2018: miRagen Therapeutics Expands Board of Directors With Appointment of Arlene Morris 36
Nov 08, 2017: miRagen Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update 37
Aug 11, 2017: miRagen Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update 39
May 10, 2017: miRagen Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update 41
Mar 31, 2017: miRagen Therapeutics Provides Corporate Update 43
Section 6 – Appendix 44
Methodology 44
Ratio Definitions 44
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
Miragen Therapeutics Inc, Key Facts 6
Miragen Therapeutics Inc, Key Employees 7
Miragen Therapeutics Inc, Key Employee Biographies 8
Miragen Therapeutics Inc, Major Products and Services 9
Miragen Therapeutics Inc, History 10
Miragen Therapeutics Inc, Subsidiaries 12
Miragen Therapeutics Inc, Key Competitors 20
Miragen Therapeutics Inc, Ratios based on current share price 21
Miragen Therapeutics Inc, Annual Ratios 22
Miragen Therapeutics Inc, Annual Ratios (Cont...1) 23
Miragen Therapeutics Inc, Interim Ratios 25
Miragen Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 27
Miragen Therapeutics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 28
Miragen Therapeutics Inc, Recent Deals Summary 29
Currency Codes 44
Capital Market Ratios 44
Equity Ratios 45
Profitability Ratios 45
Cost Ratios 46
Liquidity Ratios 46
Leverage Ratios 47
Efficiency Ratios 47

List of Figures
Miragen Therapeutics Inc, Performance Chart (2013 - 2017) 24
Miragen Therapeutics Inc, Ratio Charts 26
Miragen Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 27
Miragen Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 28

★調査レポート[Miragen Therapeutics Inc (MGEN):企業の財務・戦略的SWOT分析] (コード:DATA904C5264)販売に関する免責事項を必ずご確認ください。
★調査レポート[Miragen Therapeutics Inc (MGEN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆